Pharma Co. Shionogi Sues InterMune Over Drug Royalties
The controversy centers on a pact calling for the firms to share documents related to clinical trials each was conducting on the use of pirfenidone in idiopathic pulmonary fibrosis, a potentially fatal disorder involving scarred lung tissue.
California-based InterMune used Shionogi’s data to win European Medicines Agency approval...
Already a subscriber? Click here to login